French healthcare non-profit Doctors Without Borders has called on European lawmakers to amend a proposed law that would lead to an effective export ban.
The Compulsory Licensing (CL) legislation, which is currently being reviewed by European authorities, aims to provide public health safeguards to ensure access to affordable medicines.
The law addresses patent barriers in order to allow cross-border cooperation in the field of…
This article is available to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, summaries and commentary from the brightest minds in pharma and biotechnology for a week. If you are already a registered user please log in. If your trial period has expired, you can sign up here.
Try before you buy
• All the news that moves the needle in pharma and biotechnology.
• Exclusive features, podcasts, interviews, data analyzes and commentary from our global network of life sciences reporters.
• Get the Pharma Letter daily newsletter, free forever.
Become a subscriber
• Unrestricted access to industry-leading news, commentary and analysis in pharmaceutical and biotechnology.
• Updates on clinical trials, conferences, mergers and acquisitions, licensing, financing, regulation, patents, legal and executive appointments, commercial strategy and financial results.
• Daily report on key events in the field of pharmaceuticals and biotechnology.
• In-depth monthly briefings on board appointments and mergers and acquisitions news.
• Choose from a cost-effective annual package or a flexible monthly subscription.
